Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Q8003 vs Components in Post-Bunionectomy Pain
NCT00831051Phase 2Completed
- Sponsor
- QRxPharma Limited
- Start
- Dec 2008
- Primary completion
- Jan 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of morphine + oxycodone in postoperative pain (6 arms), sponsored by QRxPharma Limited. Primary endpoint: Difference in pain intensity scores from baseline at 48 hours. Started Dec 2008; status: completed.
02
Drugs
morphine + oxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00831051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831051.